Barinthus Biotherapeutics (BRNS) Q4 2023 Earnings

Mar 22Expected
Q2 2023
Q3 2023
Q4 2023
-0.62
-0.56
-0.51
-0.45

Details

Expected EPS
-0.5
Actual EPS
-0.45
Surprise EPS
0.05
Surprise Percent
+10%

Description

⁨Barinthus Biotherapeutics⁩ (⁦BRNS⁩) has reported earnings of ⁦-0.45⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts